The first edition of the Virtual International Renal Oncology (VIRO) Congress 2025 was officially launched under the OncoDaily Online Educational Platform, marking a major milestone in global renal cancer education and collaboration.

Featuring more than 50 distinguished speakers from leading institutions across the world, the event brought together experts in medical oncology, urology, surgery, pathology, and translational research to discuss the latest advances in kidney cancer treatment and science. Topics included immunotherapy combinations, novel targeted agents, precision medicine, and strategies to expand access to innovation in low- and middle-income countries.

The success of this inaugural VIRO Congress establishes it as an annual flagship event within OncoDaily’s growing portfolio — reinforcing its mission to advance knowledge, collaboration, and excellence in cancer care worldwide.